Perspective Therapeutics (CATX) Preferred Shares (2011 - 2014)

Perspective Therapeutics has disclosed Preferred Shares across 4 years of filings, most recently posting $59.0 for Q2 2014.

• Preferred Shares for Q2 2014 came in at $59.0, changed 0.0% year-over-year; the trailing twelve-month figure through Jun 2014 was $59.0 (changed 0.0% YoY), and the FY2014 annual result was $59.0, changed 0.0% from the prior year.
• Preferred Shares came in at $59.0 for Q2 2014 at Perspective Therapeutics, roughly flat from $59.0 in the prior quarter.
• In the past five years, Preferred Shares ranged from a high of $61.0 in Q3 2013 to a low of $59.0 in Q2 2011.
• The 4-year median for Preferred Shares is $59.0 (2011), against an average of $59.31.
• Across the five-year window, Preferred Shares changed 0.0% in 2012 and advanced 3.39% in 2013, its largest moves.
• Perspective Therapeutics' Preferred Shares stood at $59.0 in 2011, then changed by 0.0% to $59.0 in 2012, then grew by 3.39% to $61.0 in 2013, then retreated by 3.28% to $59.0 in 2014.
• The last three Preferred Shares figures came in at $59.0 (Q2 2014), $59.0 (Q1 2014), and $61.0 (Q4 2013), per Business Quant data.